Ji Cao Selected Research

Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)

1/2021	Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.
11/2015	Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ji Cao Research Topics

Disease

83	Neoplasms (Cancer) 02/2024 - 03/2003
25	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 03/2003
17	Neoplasm Metastasis (Metastasis) 04/2024 - 07/2004
16	Carcinogenesis 04/2023 - 09/2007
12	Inflammation (Inflammations) 01/2024 - 01/2017
10	Hypoxia (Hypoxemia) 01/2024 - 11/2010
10	Infections 01/2022 - 03/2005
7	Liver Neoplasms (Liver Cancer) 11/2020 - 06/2008
6	Lung Neoplasms (Lung Cancer) 01/2024 - 06/2007
5	Leukemia 01/2023 - 12/2010
5	Osteosarcoma (Osteogenic Sarcoma) 01/2020 - 01/2017
4	Fibrosis (Cirrhosis) 01/2024 - 02/2005
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2022
4	Triple Negative Breast Neoplasms 01/2023 - 01/2020
4	Parkinson Disease (Parkinson's Disease) 07/2021 - 02/2015
3	Obesity 01/2024 - 01/2020
3	Non-alcoholic Fatty Liver Disease 01/2024 - 10/2020
3	Testicular Neoplasms (Testicular Cancer) 03/2023 - 03/2003
3	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 05/2019
3	Acute Promyelocytic Leukemia 04/2022 - 10/2021
3	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2007
3	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2005
3	Thrombosis (Thrombus) 02/2016 - 07/2004
2	Insulin Resistance 01/2024 - 01/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2024 - 01/2023
2	Rhabdomyolysis 01/2024 - 01/2023
2	Heart Diseases (Heart Disease) 10/2023 - 01/2022
2	Hypertrophy 09/2023 - 01/2022
2	Necrosis 09/2023 - 01/2022
2	Alcoholism (Alcohol Abuse) 03/2023 - 07/2022
2	Heart Failure 06/2022 - 01/2022
2	Atherosclerosis 05/2022 - 05/2022
2	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2019
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 11/2021 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 05/2014
2	Colitis 01/2021 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2007
11	Messenger RNA (mRNA)IBA 01/2024 - 07/2004
8	DNA (Deoxyribonucleic Acid)IBA 03/2023 - 06/2007
8	Dehydroepiandrosterone (DHEA)IBA 01/2022 - 01/2019
6	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2023 - 01/2022
6	Lysine (L-Lysine)FDA Link 01/2022 - 01/2019
5	Protein Kinases (Protein Kinase)IBA 10/2023 - 01/2020
5	Transcription Factors (Transcription Factor)IBA 03/2022 - 11/2010
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 06/2014
5	Aflatoxin B1 (Aflatoxin B)IBA 10/2007 - 02/2004
4	LipidsIBA 01/2024 - 01/2020
4	IronIBA 01/2024 - 01/2020
4	Calcium-Calmodulin-Dependent Protein KinasesIBA 10/2023 - 01/2022
4	Therapeutic UsesIBA 04/2023 - 10/2014
4	EnzymesIBA 03/2023 - 02/2013
4	Small Interfering RNA (siRNA)IBA 04/2022 - 09/2010
4	UbiquitinIBA 01/2022 - 01/2018
4	Ligases (Synthetase)IBA 01/2022 - 01/2021
4	Sirtuin 2IBA 01/2022 - 01/2019
4	p38 Mitogen-Activated Protein KinasesIBA 10/2020 - 10/2019
3	Drug CombinationsIBA 01/2024 - 12/2016
3	Disulfiram (Antabuse)FDA Link 03/2023 - 07/2022
3	Malondialdehyde (Propanedial)IBA 01/2023 - 01/2020
3	Oncogene Proteins (Oncogene Protein)IBA 04/2022 - 02/2021
3	Deubiquitinating EnzymesIBA 04/2022 - 01/2020
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2021 - 01/2017
3	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2021 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2014
3	AntioxidantsIBA 01/2021 - 06/2008
3	SirtuinsIBA 11/2020 - 01/2017
3	Aldo-Keto ReductasesIBA 01/2020 - 01/2017
3	FenretinideIBA 01/2017 - 11/2010
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2005 - 07/2004
2	LuciferasesIBA 01/2024 - 11/2010
2	Angiotensin IIIBA 10/2023 - 01/2022
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2023 - 01/2020
2	Cullin Proteins (Cullins)IBA 03/2023 - 02/2021
2	Fatty Acid-Binding ProteinsIBA 12/2022 - 04/2012
2	retinamideIBA 07/2022 - 09/2009
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2022 - 10/2020
2	snake venom protein C activatorIBA 01/2022 - 01/2022
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 08/2020
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	Adenosine Monophosphate (AMP)IBA 01/2022 - 01/2020
2	Palmitic Acid (Hexadecanoic Acid)IBA 11/2021 - 01/2020
2	Estrogens (Estrogen)FDA Link 11/2021 - 07/2005
2	Phosphotransferases (Kinase)IBA 10/2021 - 02/2021
2	AMP-Activated Protein KinasesIBA 10/2021 - 10/2020
2	Chloroquine (Aralen)FDA LinkGeneric 10/2021 - 11/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 11/2010
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2021 - 11/2010
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021 - 11/2015
2	rho Guanine Nucleotide Dissociation Inhibitor betaIBA 01/2021 - 11/2015
2	LipopolysaccharidesIBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 01/2020
2	InflammasomesIBA 01/2021 - 01/2020
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 11/2020 - 01/2020

Therapy/Procedure

37	Therapeutics 04/2024 - 07/2009
12	Drug Therapy (Chemotherapy) 04/2024 - 06/2007
2	Radiotherapy 04/2024 - 03/2022
2	Immunotherapy 01/2023 - 01/2021
2	Neoadjuvant Therapy 10/2021 - 01/2020